Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 9

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Age-Associated Changes of Sirtuin 2 Expression in CNS and the Periphery

Garmendia-Berges, Maider, Sola-Sevilla, Noemi, Mera-Delgado, MCarmen, Puerta, Elena · 2023 · Biology

Abstract

Sirtuin 2 (SIRT2), one of the seven members of the sirtuin family, has emerged as a potential regulator of aging and age-related pathologies since several studies have demonstrated that it shows age-related changes in humans and different animal models. A detailed analysis of the relevant works published to date addressing this topic shows that the changes that occur in SIRT2 with aging seem to be opposite in the brain and in the periphery. On the one hand, aging induces an increase in SIRT2 levels in the brain, which supports the notion that its pharmacological inhibition is beneficial in different neurodegenerative diseases. However, on the other hand, in the periphery, SIRT2 levels are reduced with aging while keeping its expression is protective against age-related peripheral inflammation, insulin resistance, and cardiovascular diseases. Thus, systemic administration of any known modulator of this enzyme would have conflicting outcomes. This review summarizes the currently available information on changes in SIRT2 expression in aging and the underlying mechanisms affected, with the aim of providing evidence to determine whether its pharmacological modulation could be an effective and safe pharmacological strategy for the treatment of age-related diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biology12121476

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 100

  1. Wu, 2001, Genes, Genetics, and Epigenetics: A Correspondence, Science, 293, 1103, 10.1126/science.293.5532.1103 · DOI · Paper page
  2. Pagiatakis, 2021, Epigenetics of Aging and Disease: A Brief Overview, Aging Clin. Exp. Res., 33, 737, 10.1007/s40520-019-01430-0 · DOI
  3. Hamilton, 2011, Epigenetics: Principles and Practice, Dig. Dis., 29, 130, 10.1159/000323874 · DOI · Paper page
  4. Park, 2020, A Short Guide to Histone Deacetylases Including Recent Progress on Class II Enzymes, Exp. Mol. Med., 52, 204, 10.1038/s12276-020-0382-4 · DOI · Paper page
  5. Shoba, 2009, Function of Sirtuins in Biological Tissues, Anat. Rec., 292, 536, 10.1002/ar.20875 · DOI
  6. Sharma, A., Mahur, P., Muthukumaran, J., Singh, A.K., and Jain, M. (2023). Shedding Light on Structure, Function and Regulation of Human Sirtuins: A Comprehensive Review. 3 Biotech., 13. · DOI
  7. Chen, 2021, Sirtuin 2 (SIRT2): Confusing Roles in the Pathophysiology of Neurological Disorders, Front. Neurosci., 15, 614107, 10.3389/fnins.2021.614107 · DOI
  8. Wang, 2019, SIRT2: Controversy and Multiple Roles in Disease and Physiology, Ageing Res. Rev., 55, 100961, 10.1016/j.arr.2019.100961 · DOI · Paper page
  9. Wu, 2022, The Sirtuin Family in Health and Disease, Signal Transduct. Target. Ther., 7, 402, 10.1038/s41392-022-01257-8 · DOI · Paper page
  10. Liu, 2017, Loss of NAD-Dependent Protein Deacetylase Sirtuin-2 Alters Mitochondrial Protein Acetylation and Dysregulates Mitophagy, Antioxid. Redox Signal., 26, 849, 10.1089/ars.2016.6662 · DOI
  11. Shen, 2021, SIRT1: A Potential Therapeutic Target in Autoimmune Diseases, Front. Immunol., 12, 779177, 10.3389/fimmu.2021.779177 · DOI · Paper page
  12. Manjula, R., Anuja, K., and Alcain, F.J. (2021). SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases. Front. Pharmacol., 11. · DOI · Paper page
  13. Yang, 2022, SIRT6 Mediates Multidimensional Modulation to Maintain Organism Homeostasis, J. Cell Physiol., 237, 3205, 10.1002/jcp.30791 · DOI
  14. Tong, 2016, SIRT7 Is Activated by DNA and Deacetylates Histone H3 in the Chromatin Context, ACS Chem. Biol., 11, 742, 10.1021/acschembio.5b01084 · DOI
  15. Ji, 2022, Mitochondrial Sirtuins, Metabolism, and Aging, J. Genet. Genom., 49, 287, 10.1016/j.jgg.2021.11.005 · DOI · Paper page
  16. Zhu, 2022, Multiple Roles of SIRT2 in Regulating Physiological and Pathological Signal Transduction, Genet. Res., 2022, 9282484, 10.1155/2022/9282484 · DOI
  17. Chambers, S.M., Shaw, C.A., Gatza, C., Fisk, C.J., Donehower, L.A., and Goodell, M.A. (2007). Aging Hematopoietic Stem Cells Decline in Function and Exhibit Epigenetic Dysregulation. PLoS Biol., 5. · DOI · Paper page
  18. Anwar, 2016, Increased Expression of SIRT2 Is a Novel Marker of Cellular Senescence and Is Dependent on Wild Type P53 Status, Cell Cycle, 15, 1883, 10.1080/15384101.2016.1189041 · DOI
  19. Braidy, 2015, Differential Expression of Sirtuins in the Aging Rat Brain, Front. Cell Neurosci., 9, 167, 10.3389/fncel.2015.00167 · DOI
  20. Maxwell, 2011, The Sirtuin 2 Microtubule Deacetylase Is an Abundant Neuronal Protein That Accumulates in the Aging CNS, Hum. Mol. Genet., 20, 3986, 10.1093/hmg/ddr326 · DOI · Paper page
  21. Belloch, 2020, Early Sirtuin 2 Inhibition Prevents Age-Related Cognitive Decline in a Senescence-Accelerated Mouse Model, Neuropsychopharmacology, 45, 347, 10.1038/s41386-019-0503-8 · DOI · Paper page
  22. Akbulut, 2022, SIRT2 and FOXO3a Expressions in the Cerebral Cortex and Hippocampus of Young and Aged Male Rats: Antioxidant and Anti-Apoptotic Effects of Melatonin, Biol. Futur., 73, 71, 10.1007/s42977-021-00102-3 · DOI
  23. Wongchitrat, 2019, Alterations in the Expression of Amyloid Precursor Protein Cleaving Enzymes MRNA in Alzheimer Peripheral Blood, Curr. Alzheimer Res., 16, 29, 10.2174/1567205015666181109103742 · DOI
  24. Ye, 2023, SIRT2 Counteracts Primate Cardiac Aging via Deacetylation of STAT3 That Silences CDKN2B, Nat. Aging, 3, 1269, 10.1038/s43587-023-00486-y · DOI
  25. North, 2003, The Human Sir2 Ortholog, SIRT2, Is an NAD+-Dependent Tubulin Deacetylase, Mol. Cell, 11, 437, 10.1016/S1097-2765(03)00038-8 · DOI · Paper page
  26. Vaquero, 2006, SirT2 Is a Histone Deacetylase with Preference for Histone H4 Lys 16 during Mitosis, Genes Dev., 20, 1256, 10.1101/gad.1412706 · DOI · Paper page
  27. Michan, 2007, Sirtuins in Mammals: Insights into Their Biological Function, Biochem. J., 404, 1, 10.1042/BJ20070140 · DOI · Paper page
  28. Zhang, 2020, The Clinical Significance of SIRT2 in Malignancies: A Tumor Suppressor or an Oncogene?, Front. Oncol., 10, 1721, 10.3389/fonc.2020.01721 · DOI
  29. Zhang, 2016, ATRIP Deacetylation by SIRT2 Drives ATR Checkpoint Activation by Promoting Binding to RPA-SsDNA, Cell Rep., 14, 1435, 10.1016/j.celrep.2016.01.018 · DOI
  30. Muth, 2001, Acetylation of TAF(I)68, a Subunit of TIF-IB/SL1, Activates RNA Polymerase I Transcription, EMBO J., 20, 1353, 10.1093/emboj/20.6.1353 · DOI · Paper page
  31. Ishfaq, 2012, Acetylation Regulates Subcellular Localization of Eukaryotic Translation Initiation Factor 5A (EIF5A), FEBS Lett., 586, 3236, 10.1016/j.febslet.2012.06.042 · DOI
  32. Cha, 2017, Metabolic Control of Primed Human Pluripotent Stem Cell Fate and Function by the MiR-200c-SIRT2 Axis, Nat. Cell Biol., 19, 445, 10.1038/ncb3517 · DOI · Paper page
  33. Zhao, 2013, Lysine-5 Acetylation Negatively Regulates Lactate Dehydrogenase A and Is Decreased in Pancreatic Cancer, Cancer Cell, 23, 464, 10.1016/j.ccr.2013.02.005 · DOI · Paper page
  34. Gomes, 2015, Emerging Role of Sirtuin 2 in the Regulation of Mammalian Metabolism, Trends Pharmacol. Sci., 36, 756, 10.1016/j.tips.2015.08.001 · DOI · Paper page
  35. Zhang, 2022, Quantitative Proteomic Analysis of the Lysine Acetylome Reveals Diverse SIRT2 Substrates, Sci. Rep., 12, 3822, 10.1038/s41598-022-06793-5 · DOI
  36. Crocco, 2016, Polymorphisms Falling Within Putative MiRNA Target Sites in the 3’UTR Region of SIRT2 and DRD2 Genes Are Correlated With Human Longevity, J. Gerontol. Ser. A Biol. Sci. Med. Sci., 71, 586, 10.1093/gerona/glv058 · DOI
  37. He, 2020, An Acetylation Switch of the NLRP3 Inflammasome Regulates Aging-Associated Chronic Inflammation and Insulin Resistance, Cell Metab., 31, 580, 10.1016/j.cmet.2020.01.009 · DOI · Paper page
  38. Sola-Sevilla, N., Ricobaraza, A., Hernandez-Alcoceba, R., Aymerich, M.S., Tordera, R.M., and Puerta, E. (2021). Understanding the Potential Role of Sirtuin 2 on Aging: Consequences of SIRT2.3 Overexpression in Senescence. Int. J. Mol. Sci., 22. · DOI
  39. Wang, 2012, Deacetylation of FOXO3 by SIRT1 or SIRT2 Leads to Skp2-Mediated FOXO3 Ubiquitination and Degradation, Oncogene, 31, 1546, 10.1038/onc.2011.347 · DOI · Paper page
  40. Wang, 2007, SIRT2 Deacetylates FOXO3a in Response to Oxidative Stress and Caloric Restriction, Aging Cell, 6, 505, 10.1111/j.1474-9726.2007.00304.x · DOI · Paper page
  41. 2014, Oxidative Stress Activates the Transcription Factors FoxO 1a and FoxO 3a in the Hippocampus of Rats Exposed to Low Doses of Ozone, Oxid. Med. Cell Longev., 2014, 805764
  42. Lynn, 2008, SIRT2 Is a Negative Regulator of Anoxia–Reoxygenation Tolerance via Regulation of 14-3-3 ζ and BAD in H9c2 Cells, FEBS Lett., 582, 2857, 10.1016/j.febslet.2008.07.016 · DOI
  43. Nie, 2014, SIRT2 Mediates Oxidative Stress-Induced Apoptosis of Differentiated PC12 Cells, Neuroreport, 25, 838, 10.1097/WNR.0000000000000192 · DOI
  44. Sarikhani, 2018, SIRT2 Regulates Oxidative Stress-Induced Cell Death through Deacetylation of c-Jun NH2-Terminal Kinase, Cell Death Differ., 25, 1638, 10.1038/s41418-018-0069-8 · DOI
  45. She, 2018, SIRT2 Inhibition Confers Neuroprotection by Downregulation of FOXO3a and MAPK Signaling Pathways in Ischemic Stroke, Mol. Neurobiol., 55, 9188, 10.1007/s12035-018-1058-0 · DOI
  46. Pino, 2014, FOXO3 Determines the Accumulation of α-Synuclein and Controls the Fate of Dopaminergic Neurons in the Substantia Nigra, Hum. Mol. Genet., 23, 1435, 10.1093/hmg/ddt530 · DOI
  47. Qin, 2008, Regulation of Forkhead Transcription Factor FoxO3a Contributes to Calorie Restriction-Induced Prevention of Alzheimer’s Disease-Type Amyloid Neuropathology and Spatial Memory Deterioration, Ann. N.Y. Acad. Sci., 1147, 335, 10.1196/annals.1427.024 · DOI
  48. Garg, 2017, Antiaging Effect of Metformin on Brain in Naturally Aged and Accelerated Senescence Model of Rat, Rejuvenation Res., 20, 173, 10.1089/rej.2016.1883 · DOI · Paper page
  49. Gal, 2012, SIRT2 Interferes with Autophagy-Mediated Degradation of Protein Aggregates in Neuronal Cells under Proteasome Inhibition, Neurochem. Int., 61, 992, 10.1016/j.neuint.2012.07.010 · DOI
  50. Inoue, 2014, SIRT2 Knockdown Increases Basal Autophagy and Prevents Postslippage Death by Abnormally Prolonging the Mitotic Arrest That Is Induced by Microtubule Inhibitors, FEBS J., 281, 2623, 10.1111/febs.12810 · DOI
  51. Li, 2023, Cooperative Effects of SIRT1 and SIRT2 on APP Acetylation, Aging Cell, 22, e13967, 10.1111/acel.13967 · DOI
  52. Kireev, 2013, Growth Hormone and Melatonin Prevent Age-Related Alteration in Apoptosis Processes in the Dentate Gyrus of Male Rats, Biogerontology, 14, 431, 10.1007/s10522-013-9443-6 · DOI
  53. Yudoh, 2015, Age-Related Decrease of Sirtuin 2 Protein in Human Peripheral Blood Mononuclear Cells, Curr. Aging Sci., 8, 256, 10.2174/1874609808999150831112939 · DOI · Paper page
  54. Zhang, 2023, Sirtuin 2 Deficiency Aggravates Ageing-Induced Vascular Remodelling in Humans and Mice, Eur. Heart J., 44, 2746, 10.1093/eurheartj/ehad381 · DOI · Paper page
  55. North, 2014, SIRT2 Induces the Checkpoint Kinase BubR1 to Increase Lifespan, EMBO J., 33, 1438, 10.15252/embj.201386907 · DOI · Paper page
  56. (2022). 2022 Alzheimer’s Disease Facts and Figures. Alzheimer’s Dement., 18, 700–789. · DOI · Paper page
  57. Aleixo, 2023, SIRT2 Inhibition Rescues Neurodegenerative Pathology but Increases Systemic Inflammation in a Transgenic Mouse Model of Alzheimer’s Disease, J. Neuroimmune Pharmacol., 18, 529, 10.1007/s11481-023-10084-9 · DOI · Paper page
  58. Silva, 2017, Mitochondrial Metabolism Power SIRT2-Dependent Deficient Traffic Causing Alzheimer’s-Disease Related Pathology, Mol. Neurobiol., 54, 4021, 10.1007/s12035-016-9951-x · DOI
  59. Singh, 2017, Sirtuin-2 Protects Neural Cells from Oxidative Stress and Is Elevated in Neurodegeneration, Parkinsons Dis., 2017, 1, 10.1155/2017/2643587 · DOI
  60. Yun, 2021, Inhibitor of DNA Binding 2 (Id2) Mediates Microtubule Polymerization in the Brain by Regulating AK40 Acetylation of α-Tubulin, Cell Death Discov., 7, 257, 10.1038/s41420-021-00652-4 · DOI
  61. Gaetani, L., Bellomo, G., Parnetti, L., Blennow, K., Zetterberg, H., and Di Filippo, M. (2021). Neuroinflammation and Alzheimer’s Disease: A Machine Learning Approach to CSF Proteomics. Cells, 10. · DOI
  62. Puerta, 2024, SIRT2 as a Potential New Therapeutic Target for Alzheimer’s Disease, Neural Regen. Res., 19, 125
  63. Biella, 2016, Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-β Protein Precursor Processing in Two Alzheimer’s Disease Mouse Models, J. Alzheimer’s Dis., 53, 1193, 10.3233/JAD-151135 · DOI · Paper page
  64. Wang, 2020, RTN4B-Mediated Suppression of Sirtuin 2 Activity Ameliorates β-Amyloid Pathology and Cognitive Impairment in Alzheimer’s Disease Mouse Model, Aging Cell, 19, e13194, 10.1111/acel.13194 · DOI · Paper page
  65. Bai, 2022, Inhibition of SIRT2 Promotes APP Acetylation and Ameliorates Cognitive Impairment in APP/PS1 Transgenic Mice, Cell Rep., 40, 111062, 10.1016/j.celrep.2022.111062 · DOI · Paper page
  66. Moore, 2005, Molecular Pathophysiology of Parkinson’s Disease, Annu. Rev. Neurosci., 28, 57, 10.1146/annurev.neuro.28.061604.135718 · DOI · Paper page
  67. Shihabuddin, 2018, New Frontiers in Parkinson’s Disease: From Genetics to the Clinic, J. Neurosci., 38, 9375, 10.1523/JNEUROSCI.1666-18.2018 · DOI
  68. Wang, 2015, Aging-Related Rotenone-Induced Neurochemical and Behavioral Deficits: Role of SIRT2 and Redox Imbalance, and Neuroprotection by AK-7, Drug Des. Devel Ther., 9, 2553, 10.2147/DDDT.S81539 · DOI
  69. Guan, 2016, Aging-Related 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Neurochemial and Behavioral Deficits and Redox Dysfunction: Improvement by AK-7, Exp. Gerontol., 82, 19, 10.1016/j.exger.2016.05.011 · DOI
  70. Sun, 2018, MicroRNA-212-5p Prevents Dopaminergic Neuron Death by Inhibiting SIRT2 in MPTP-Induced Mouse Model of Parkinson’s Disease, Front. Mol. Neurosci., 11, 381, 10.3389/fnmol.2018.00381 · DOI · Paper page
  71. Chen, X., Mai, H., Chen, X., Cai, Y., Cheng, Q., Chen, X., Li, X., Fan, W., Tang, P., and Ou, M. (2019). Rs2015 Polymorphism in MiRNA Target Site of Sirtuin2 Gene Is Associated with the Risk of Parkinson’s Disease in Chinese Han Population. Biomed. Res. Int., 2019. · DOI
  72. Chen, X., Wales, P., Quinti, L., Zuo, F., Moniot, S., Herisson, F., Rauf, N.A., Wang, H., Silverman, R.B., and Ayata, C. (2015). The Sirtuin-2 Inhibitor AK7 Is Neuroprotective in Models of Parkinson’s Disease but Not Amyotrophic Lateral Sclerosis and Cerebral Ischemia. PLoS ONE, 10. · DOI
  73. Esteves, 2018, Mitochondrial Metabolism Regulates Microtubule Acetylome and Autophagy Trough Sirtuin-2: Impact for Parkinson’s Disease, Mol. Neurobiol., 55, 1440, 10.1007/s12035-017-0420-y · DOI
  74. Yan, 2022, Cdk5 Phosphorylation-Induced SIRT2 Nuclear Translocation Promotes the Death of Dopaminergic Neurons in Parkinson’s Disease, NPJ Parkinsons Dis., 8, 46, 10.1038/s41531-022-00311-0 · DOI
  75. Outeiro, 2007, Sirtuin 2 Inhibitors Rescue Alpha-Synuclein-Mediated Toxicity in Models of Parkinson’s Disease, Science, 317, 516, 10.1126/science.1143780 · DOI · Paper page
  76. Zacharioudakis, 2015, The Discovery of a Highly Selective 5,6,7,8-Tetrahydrobenzo[4,5]Thieno[2,3-d]Pyrimidin-4(3H)-One SIRT2 Inhibitor That Is Neuroprotective in an in Vitro Parkinson’s Disease Model, ChemMedChem, 10, 69, 10.1002/cmdc.201402431 · DOI
  77. De Oliveira, R.M., Vicente Miranda, H., Francelle, L., Pinho, R., Szegö, É.M., Martinho, R., Munari, F., Lázaro, D.F., Moniot, S., and Guerreiro, P. (2017). The Mechanism of Sirtuin 2-Mediated Exacerbation of Alpha-Synuclein Toxicity in Models of Parkinson Disease. PLoS Biol., 15. · DOI
  78. Li, 2016, MicroRNA-7 Inhibits Neuronal Apoptosis in a Cellular Parkinson’s Disease Model by Targeting Bax and Sirt2, Am. J. Transl. Res., 8, 993
  79. Wang, 2018, MiR-486-3p Influences the Neurotoxicity of a-Synuclein by Targeting the SIRT2 Gene and the Polymorphisms at Target Sites Contributing to Parkinson’s Disease, Cell Physiol. Biochem., 51, 2732, 10.1159/000495963 · doi:10.1159/000495963
  80. Young, 2003, Huntingtin in Health and Disease, J. Clin. Investig., 111, 299, 10.1172/JCI17742 · DOI
  81. Baldo, 2019, SIRT1 Is Increased in Affected Brain Regions and Hypothalamic Metabolic Pathways Are Altered in Huntington Disease, Neuropathol. Appl. Neurobiol., 45, 361, 10.1111/nan.12514 · DOI
  82. Taylor, 2010, SIRT2 Inhibition Achieves Neuroprotection by Decreasing Sterol Biosynthesis, Proc. Natl. Acad. Sci. USA, 107, 7927, 10.1073/pnas.1002924107 · DOI · Paper page
  83. Chopra, 2012, The Sirtuin 2 Inhibitor AK-7 Is Neuroprotective in Huntington’s Disease Mouse Models, Cell Rep., 2, 1492, 10.1016/j.celrep.2012.11.001 · DOI · Paper page
  84. Pallos, 2008, Inhibition of Specific HDACs and Sirtuins Suppresses Pathogenesis in a Drosophila Model of Huntington’s Disease, Hum. Mol. Genet., 17, 3767, 10.1093/hmg/ddn273 · DOI · Paper page
  85. Quinti, 2016, SIRT2- and NRF2-Targeting Thiazole-Containing Compound with Therapeutic Activity in Huntington’s Disease Models, Cell Chem. Biol., 23, 849, 10.1016/j.chembiol.2016.05.015 · DOI
  86. Taylor, 2011, A Brain-Permeable Small Molecule Reduces Neuronal Cholesterol by Inhibiting Activity of Sirtuin 2 Deacetylase, ACS Chem. Biol., 6, 540, 10.1021/cb100376q · DOI
  87. Bobrowska, A., Donmez, G., Weiss, A., Guarente, L., and Bates, G. (2012). SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington’s Disease Phenotypes in Vivo. PLoS ONE, 7. · DOI
  88. Liscic, 2020, From Basic Research to the Clinic: Innovative Therapies for ALS and FTD in the Pipeline, Mol. Neurodegener., 15, 31, 10.1186/s13024-020-00373-9 · DOI
  89. Valle, 2014, Tissue-Specific Deregulation of Selected HDACs Characterizes ALS Progression in Mouse Models: Pharmacological Characterization of SIRT1 and SIRT2 Pathways, Cell Death Dis., 5, e1296, 10.1038/cddis.2014.247 · DOI
  90. Taes, 2013, Hdac6 Deletion Delays Disease Progression in the SOD1G93A Mouse Model of ALS, Hum. Mol. Genet., 22, 1783, 10.1093/hmg/ddt028 · DOI
  91. Banerjee, 2022, NLRP3 Inflammasome as a Key Molecular Target Underlying Cognitive Resilience in Amyotrophic Lateral Sclerosis, J. Pathol., 256, 262, 10.1002/path.5846 · DOI
  92. Fusco, R., Siracusa, R., Genovese, T., Cuzzocrea, S., and Di Paola, R. (2020). Focus on the Role of NLRP3 Inflammasome in Diseases. Int. J. Mol. Sci., 21. · DOI · Paper page
  93. Malhotra, 2021, Targeting Inflammasomes to Treat Neurological Diseases, Ann. Neurol., 90, 177, 10.1002/ana.26158 · DOI
  94. Zhou, 2018, Recent Advances in Inhibitors of Sirtuin1/2: An Update and Perspective, Future Med. Chem., 10, 907, 10.4155/fmc-2017-0207 · DOI
  95. Suzuki, 2012, Design, Synthesis, and Biological Activity of a Novel Series of Human Sirtuin-2-Selective Inhibitors, J. Med. Chem., 55, 5760, 10.1021/jm3002108 · DOI
  96. Erburu, 2017, SIRT2 Inhibition Modulate Glutamate and Serotonin Systems in the Prefrontal Cortex and Induces Antidepressant-like Action, Neuropharmacology, 117, 195, 10.1016/j.neuropharm.2017.01.033 · DOI · Paper page
  97. Sakai, 2015, Design, Synthesis and Structure–Activity Relationship Studies of Novel Sirtuin 2 (SIRT2) Inhibitors with a Benzamide Skeleton, Bioorganic Med. Chem., 23, 328, 10.1016/j.bmc.2014.11.027 · DOI
  98. Yeong, K.Y., Khaw, K.Y., Takahashi, Y., Itoh, Y., Murugaiyah, V., and Suzuki, T. (2020). Discovery of Gamma-Mangostin from Garcinia Mangostana as a Potent and Selective Natural SIRT2 Inhibitor. Bioorganic Chem., 94. · DOI
  99. Singh, 2021, Design and in Vitro Analysis of SIRT2 Inhibitor Targeting Parkinson’s Disease, Mol. Divers., 25, 2261, 10.1007/s11030-020-10116-z · DOI
  100. Djokovic, N., Rahnasto-Rilla, M., Lougiakis, N., Lahtela-Kakkonen, M., and Nikolic, K. (2023). SIRT2i_Predictor: A Machine Learning-Based Tool to Facilitate the Discovery of Novel SIRT2 Inhibitors. Pharmaceuticals, 16. · DOI

Cited by

See all 9

Metadata

Authors
Garmendia-Berges, M., Sola-Sevilla, N., Mera-Delgado, M., & Puerta, E.
Affiliations
Pharmaceutical Sciences Department, Division of Pharmacology, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain
Venue
Biology
Publisher
MDPI AG
Published
2023-11-29
Volume
12
Issue
12
Pages
1476
ISSN
2079-7737
Cited by
9
References
7
Language
en
Funders
  • FEDER/Ministerio de Ciencia, Innovación y Universidades Agencia Estatal de Investigación/ Project (PID2020-119729GB-100, REF/AEI/10.13039/501100011033)
  • Spanish Ministry of Universities (FPU) (PID2020-119729GB-100, REF/AEI/10.13039/501100011033)
  • Programa MRR Investigo 2023 (PID2020-119729GB-100, REF/AEI/10.13039/501100011033)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Age-Associated Changes of Sirtuin 2 Expression in CNS and the Periphery. https://app.cochat.ai/papers/10.3390/biology12121476
The paper
Garmendia-Berges, M., Sola-Sevilla, N., Mera-Delgado, M., & Puerta, E. (2023). Age-Associated Changes of Sirtuin 2 Expression in CNS and the Periphery. Biology. https://doi.org/10.3390/biology12121476

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.